Cloning and characterization of complementary DNA encoding human N-acetylglucosamine-phosphate mutase protein.
Endothelial cells express erythropoietin receptor (EpoR) and are responsive to erythropoietin (Epo). Upon ligand binding, EpoR activates multiple signaling cascades. Identification of genes expressed in response to Epo is important for understanding the molecular nature of the signals. Applying the differential display approach, an effective method for analysis of gene expression, we identified five differentially expressed mRNAs. In this study, we cloned human N-acetylglucosamine-phosphate mutase from a human microvascular endothelial cell (HMVEC) cDNA library using one of the differentially expressed fragments as a probe. The nucleotide (nt) sequence analysis of the longest clone displayed a 2 kb cDNA fragment and encodes a protein of approximately 542 amino acids with a predicted MW of approximately 60 kDa. Northern blotting and reverse transcriptase-polymerase chain reaction analysis revealed an upregulation of the N-acetylglucosamine-phosphate mutase mRNA after 2 h of stimulation of cells with Epo. This gene was shown to be variably expressed in human tissues and is located on chromosome 6. These studies demonstrate that the expression of N-acetylglucosamine-phosphate mutase mRNA responds to cytokines, and the presence of a 10 aa motif similar to the putative active site of several hexose-phosphate mutases provides a basis for future studies of the role of this gene in the regulation of Epo-stimulated endothelial cell proliferation.
Li
C
C
Department of Membrane Biochemistry II, The Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY 10021, USA.
Rodriguez
M
M
Banerjee
D
D
D000595:Amino Acid Sequence; D000818:Animals; D001483:Base Sequence; D002874:Chromosome Mapping; D002896:Chromosomes, Human, Pair 6 / Q000235:genetics; D003001:Cloning, Molecular; D006224:Cricetinae; D018076:DNA, Complementary / Q000737:chemistry / Q000235:genetics*; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D004921:Erythropoietin / Q000494:pharmacology; D005260:Female; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D006822:Hybrid Cells; D051379:Mice; D008969:Molecular Sequence Data; D017875:Phosphotransferases (Phosphomutases) / Q000235:genetics*; D012333:RNA, Messenger / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D017422:Sequence Analysis, DNA; D014018:Tissue Distribution
D018076:DNA, Complementary; D012333:RNA, Messenger; D004921:Erythropoietin; D017875:Phosphotransferases (Phosphomutases); C018718:phosphoacetylglucosamine mutase